Results 161 to 170 of about 40,684 (247)

Invalid Nucleic Acid Test Results May Limit Deceased Donor Organ Utilization

Transplant Infectious Disease, EarlyView.
Rare instances occur in which discriminatory NAT results cannot be resolved in deceased organ donor cases. When these events occur the impact on organ donation can be substantial. ABSTRACT Background Nucleic acid testing (NAT) is essential for detecting transmissible viral infections in deceased organ donors and guiding safe organ allocation.
Sara Dionne, Hillary Akana, Kaitlin Logue, Brenden O'Neale, Chris Curran, Sean VanSlyck   +5 more
wiley   +1 more source

Incidence and outcomes of major bleeding among first-time oral factor Xa inhibitor users: multinational observational cohort studies. [PDF]

Res Pract Thromb Haemost
Cohen AT, Welsh RC, Leentjens J, Canbay A, Choudhuri S, Er C, Chai-Adisaksopha C, Dover DC, Smits E, Mamza JB, Gao H, Zhang R, Randhawa AK, Beekman W, Scherg F, Palacios B, Godfrey G, Lang E, Arenillas J, Coleman CI, AXIOM Research Group.   +20 more
europepmc   +1 more source

Acute pain transfusion reaction in a patient with thalassemia: In‐depth characterization of short‐ and long‐term phenotypes

Transfusion, EarlyView.
Abstract Background Acute pain transfusion reaction (APTR) is a rare, under‐recognized condition of unknown etiology. It can cause significant distress in recipients, necessitating symptomatic management and, occasionally, hospitalization. Study Design and Methods Here, we present an APTR event in an adult subject with transfusion‐dependent thalassemia
Georgia Tzafa, Sophia Delicou, Ioanna Barla, Konstantina Theocharaki, Aggeliki Kondi, Athanassios D. Velentzas, Nikolaos Simantiris, Elli‐Anna Stylianaki, George Mpekoulis, Efthymia Pavlou, Niki Vassilaki, Ioannis V. Kostopoulos, Aikaterini Xydaki, Efrosyni Nomikou, Ioanna‐Katerina Aggeli, Nikolaos Thomaidis, Evangelos Gikas, Martina Samiotaki, Jerome Zoidakis, Constantina Politis, Marianna H. Antonelou   +20 more
wiley   +1 more source

Andexanet alfa vs standard of care for factor Xa inhibitor-induced intracranial hemorrhage-a systematic review and meta-analysis. [PDF]

Res Pract Thromb Haemost
Xiang AJ, Sadafi SL, Principato R, Shaikh A, Nowrouzi M, Eshaghpour A, Li A, Crowther M.   +7 more
europepmc   +1 more source

Factor Xa; factor XIa; kallikrein [PDF]

Science-Business eXchange, 2013
openaire   +1 more source

Position statement of the Polish Society of Gastroenterology on the use of andexanet alfa in patients with gastrointestinal bleeding taking factor Xa inhibitors. [PDF]

Prz Gastroenterol
Adrych K, Daniluk J, Nowakowska-Duława E, Białek A, Rydzewska GM.   +4 more
europepmc   +1 more source

Monitoring anti-factor Xa activity in patients with chronic thromboembolic pulmonary hypertension treated with factor Xa inhibitors. [PDF]

Sci Rep
Nakano Y, Adachi S, Hirose M, Adachi T, Nishiyama I, Yasuda K, Yoshida M, Kondo T, Murohara T.   +8 more
europepmc   +1 more source

On the automorphisms of the power semigroups of a numerical semigroup

Transactions of the London Mathematical Society, Volume 13, Issue 1, December 2026.
Abstract If H$H$ is a numerical semigroup (i.e., a cofinite subset of the non‐negative integers closed under addition), then the collection of all non‐empty subsets of H$H$ forms a semigroup P(H)$\mathcal {P}(H)$ under the sumset operation induced by addition in H$H$.
Salvatore Tringali, Kerou Wen
wiley   +1 more source

Detrimental Effect of Plasma From Patients With Severe Aortic Stenosis on Valvular Endothelial Cells: Role of Proinflammatory Cytokines and Factor Xa. [PDF]

J Am Heart Assoc
Trimaille A, Hmadeh S, Kikuchi S, Mroueh A, Carmona A, Marchandot B, Beras F, Truong DP, Vu MC, Granier A, Jesel L, Ohlmann P, Sattler L, Schini-Kerth V, Morel O.   +14 more
europepmc   +1 more source

Bioresorbable Scaffolds for Coronary Arteries: Where Do We Stand Today?

VIEW Medicine, Volume 1, Issue 1, August 2026.
Bioresorbable coronary scaffolds are moving from thick strut pitfalls to thinner, stronger, healing‐oriented designs. Integrating advances in materials, guided implantation with preparation, size, and postdilation steps, and resorption aligned to healing, we synthesize clinical evidence and chart a roadmap toward intelligent, transient platforms ...
Junya Matsuda, Tatsuya Watanabe, Satoshi Yuhara, John M. Kelly, Hirotsugu Kurobe, Toshiharu Shinoka   +5 more
wiley   +1 more source